21 studies found for:    Open Studies | "Eyelid Diseases"
Show Display Options
Rank Status Study
1 Recruiting Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice
Conditions: Palpebral Pathologies;   Ocular Surface Disease;   Meibomian Gland Dysfunction
Intervention:
2 Unknown  Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial Spasm
Conditions: Blepharospasm;   Hemifacial Spasm
Interventions: Drug: Zinc Supplement;   Drug: Sugar pill
3 Recruiting Demodex Blepharitis Treatment Study
Condition: Chronic Blepharitis
Interventions: Drug: Terpinen-4-ol;   Other: Placebo
4 Recruiting Chalazia Treatment Study
Condition: Chalazion
Interventions: Drug: 5-fluorouracil Injection;   Drug: Triamcinolone Acetonide;   Procedure: Incision and Curettage;   Drug: Triamcinolone Acetonide/5-fluorouracil mixture
5 Unknown  Comparison of Postoperative Pain With Two Different Types of Local Anesthesia in Surgery for a Drooping Eyelid
Condition: Blepharoptosis
Interventions: Procedure: Frontal nerve block with 2% lidocaine with 1:100,000 dilution of epinephrine;   Procedure: Subconjunctival injection of 2% lidocaine with 1:100,000 dilution with epinephrine
6 Recruiting Lacrimal Drainage Resistance Study
Conditions: Epiphora;   Nasolacrimal Duct Obstruction;   Canalicular Stenosis;   Functional Tear Pump Failure;   Ectropion
Intervention:
7 Not yet recruiting Intralesional Tetracycline Injection in the Treatment of Chalazia
Conditions: Chalazia;   Chalazion
Intervention: Drug: Tetracycline
8 Recruiting Identification of TT Cases by Community Treatment Assistants: An Assessment
Condition: Trichiasis
Intervention: Other: TT Training Program and Recognition Card
9 Not yet recruiting Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm
Condition: Pupillary Occlusion
Intervention:
10 Recruiting Acetyl Hexapeptide-8 for Blepharospasm
Condition: Focal Dystonia
Intervention: Drug: Topical acetyl hexapeptide-8
11 Unknown  Lipids of the Human Tear Film and Their Effect on Tear Stability
Condition: Blepharitis
Interventions: Drug: doxycycline;   Drug: essential fatty acid;   Drug: azithromycin
12 Recruiting Hyaluronic Acid Gels for Lower Lid Retraction
Condition: Ectropion
Interventions: Procedure: Hyaluronic acid;   Procedure: Saline
13 Recruiting Fluorometholone as Ancillary Therapy for TT Surgery
Conditions: Trichiasis;   Trachoma;   Bilamellar Tarsal Rotation
Interventions: Drug: Fluorometholone 0.1% ophthalmic solution;   Other: Artificial tears (Placebo)
14 Recruiting Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Conditions: Blepharitis;   Dry Eye Syndrome
Interventions: Device: LipiFlow Pre-Treatment;   Device: LipiFlow Post-treatment
15 Unknown  Comparison of Argon Laser and Radiofrequency in Trichiasis Treatment
Condition: Trichiasis
Intervention: Procedure: argon laser and radiofrequency
16 Not yet recruiting Comparative Study to Evaluate ISV-305 Compared to Vehicle in Non-Bacterial Blepharitis Subjects
Condition: Non-Bacterial Blepharitis
Interventions: Drug: ISV-305;   Other: Vehicle
17 Unknown  Comparison of Combination Antibiotics Eyedrop to Artificial Tear in Hordeolum After Incision and Curettage
Condition: Hordeolum
Interventions: Drug: neomycin sulfate, polymyxin B sulfate and gramicidin;   Drug: Artificial tear
18 Unknown  Chalazion Treatment Trial
Condition: Eyelid Chalazion
Interventions: Drug: Tobrex Drops and Ointment;   Drug: Tobradex Drops and Ointment;   Drug: Warm Compresses
19 Not yet recruiting Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
Conditions: Ocular Inflammation;   Infection Associated Blepharitis;   Keratitis;   Conjunctivitis, Bacterial
Interventions: Drug: azithromycin 1.5%/Loteprednol 0,5% + placebo;   Drug: azithromycin 1.5% + Loteprednol 0,5% (separately)
20 Recruiting Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid
Condition: Bilateral Blepharospasm (BEB)
Interventions: Drug: IncobulinumtoxinA (Xeomin), 25 Units;   Drug: IncobotulinumtoxinA (Xeomin), 12.5 Units;   Drug: Placebo;   Drug: IncobotulinumtoxinA (Xeomin), 35 Units

Previous Page Studies Shown (1-20) Next Page (21-21) Show next page of results
Indicates status has not been verified in more than two years